1
|
Edwards LJ, Fowlkes AL, Wesley MG, Kuntz JL, Odean MJ, Caban-Martinez AJ, Dunnigan K, Phillips AL, Grant L, Herring MK, Groom HC, Respet K, Beitel S, Zunie T, Hegmann KT, Kumar A, Joseph G, Poe B, Louzado-Feliciano P, Smith ME, Thiese MS, Schaefer-Solle N, Yoo YM, Silvera CA, Mayo Lamberte J, Mak J, McDonald LC, Stuckey MJ, Kutty P, Arvay ML, Yoon SK, Tyner HL, Burgess JL, Hunt DR, Meece J, Gaglani M, Naleway AL, Thompson MG. Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort Study. JMIR Res Protoc 2021; 10:e31574. [PMID: 34662287 PMCID: PMC8647972 DOI: 10.2196/31574] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2021] [Revised: 10/06/2021] [Accepted: 10/07/2021] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND Workers critical to emergency response and continuity of essential services during the COVID-19 pandemic are at a disproportionally high risk of SARS-CoV-2 infection. Prospective cohort studies are needed for enhancing the understanding of the incidence of symptomatic and asymptomatic SARS-CoV-2 infections, identifying risk factors, assessing clinical outcomes, and determining the effectiveness of vaccination. OBJECTIVE The Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER) prospective cohort study was designed to estimate the incidence of symptomatic and asymptomatic SARS-CoV-2 infections, examine the risk factors for infection and clinical spectrum of illness, and assess the effectiveness of vaccination among essential workers. METHODS The RECOVER multisite network was initiated in August 2020 and aims to enroll 3000 health care personnel (HCP), first responders, and other essential and frontline workers (EFWs) at 6 US locations. Data on participant demographics, medical history, and vaccination history are collected at baseline and throughout the study. Active surveillance for the symptoms of COVID-19-like illness (CLI), access of medical care, and symptom duration is performed by text messages, emails, and direct participant or medical record reports. Participants self-collect a mid-turbinate nasal swab weekly, regardless of symptoms, and 2 additional respiratory specimens at the onset of CLI. Blood is collected upon enrollment, every 3 months, approximately 28 days after a reverse transcription polymerase chain reaction (RT-PCR)-confirmed SARS-CoV-2 infection, and 14 to 28 days after a dose of any COVID-19 vaccine. From February 2021, household members of RT-PCR-confirmed participants are self-collecting mid-turbinate nasal swabs daily for 10 days. RESULTS The study observation period began in August 2020 and is expected to continue through spring 2022. There are 2623 actively enrolled RECOVER participants, including 280 participants who have been found to be positive for SARS-CoV-2 by RT-PCR. Enrollment is ongoing at 3 of the 6 study sites. CONCLUSIONS Data collected through the cohort are expected to provide important public health information for essential workers at high risk for occupational exposure to SARS-CoV-2 and allow early evaluation of COVID-19 vaccine effectiveness. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) DERR1-10.2196/31574.
Collapse
Affiliation(s)
| | - Ashley L Fowlkes
- Centers for Disease Control and Prevention, Atlanta, GA, United States
| | | | - Jennifer L Kuntz
- Kaiser Permanente Northwest Center for Health Research, Portland, OR, United States
| | - Marilyn J Odean
- Whiteside Institute for Clinical Research, Duluth, MN, United States
- St. Luke's Regional Health Care System, Duluth, MN, United States
| | | | - Kayan Dunnigan
- Baylor Scott and White Health, Temple, TX, United States
| | | | - Lauren Grant
- Centers for Disease Control and Prevention, Atlanta, GA, United States
| | | | - Holly C Groom
- Kaiser Permanente Northwest Center for Health Research, Portland, OR, United States
| | - Karley Respet
- St. Luke's Regional Health Care System, Duluth, MN, United States
| | - Shawn Beitel
- University of Arizona, Tucson, AZ, United States
| | - Tnelda Zunie
- Baylor Scott and White Health, Temple, TX, United States
| | | | - Archana Kumar
- Centers for Disease Control and Prevention, Atlanta, GA, United States
| | - Gregory Joseph
- Centers for Disease Control and Prevention, Atlanta, GA, United States
| | - Brandon Poe
- Abt Associates, Inc, Atlanta, GA, United States
| | | | | | | | | | - Young M Yoo
- Centers for Disease Control and Prevention, Atlanta, GA, United States
| | | | | | - Josephine Mak
- Centers for Disease Control and Prevention, Atlanta, GA, United States
| | | | - Matthew J Stuckey
- Centers for Disease Control and Prevention, Atlanta, GA, United States
| | - Preeta Kutty
- Centers for Disease Control and Prevention, Atlanta, GA, United States
| | - Melissa L Arvay
- Centers for Disease Control and Prevention, Atlanta, GA, United States
| | - Sarang K Yoon
- University of Utah, Salt Lake City, UT, United States
| | - Harmony L Tyner
- St. Luke's Regional Health Care System, Duluth, MN, United States
| | | | | | - Jennifer Meece
- Marshfield Clinic Research Institute, Marshfield, WI, United States
| | - Manjusha Gaglani
- Baylor Scott and White Health, Temple, TX, United States
- Texas A&M University College of Medicine, Temple, TX, United States
| | - Allison L Naleway
- Kaiser Permanente Northwest Center for Health Research, Portland, OR, United States
| | - Mark G Thompson
- Centers for Disease Control and Prevention, Atlanta, GA, United States
| |
Collapse
|